Infections Higher With JAK Inhibitors in Eczema Study

TOPLINE: Janus kinase (JAK) inhibitors were associated with more infections, particularly herpes infections, in patients with atopic dermatitis (AD) compared with biologics, in a cohort study. METHODOLOGY: A prospective, multicenter observational study included 1793 patients (age, ≥ 12 years) with moderate to severe AD from the Dutch BioDay registry between October 2017 and July 2024. … Read more

Pandemic Lockdowns Goosed Group A Strep Strains

Investigators in Canada have discovered that molecular changes to an infectious bacterium (Group A Streptococcus pyogenes [GAS]) underlie a post-pandemic surge of coinfections with a respiratory diagnosis, prompting one expert to suggest lockdowns during the pandemic might have created an immunity deficiency in hosts while at the same time helping the bacteria create newly virulent … Read more

Clinical symptoms and molecular epidemiologic characteristics of varicella patients among children and adults in Ganzhou, China | Virology Journal

Characteristics of the study population A total of 39 patients with varicella were admitted to Ganzhou Fifth People’s Hospital from August 2021 to December 2022. The median age was 13.0 (8.0, 27.0) years, with a male-to-female ratio of 22:17. In the present study, patients with varicella were categorized into two groups, children and adults, according … Read more

Shingles Vaccine Market to hit USD 12.9 billion by 2034,

Selbyville, Delaware, Jan. 22, 2025 (GLOBE NEWSWIRE) — Shingles vaccine market size was valued at USD 4.9 billion in 2024 and is projected to grow at a robust CAGR of 10.1% from 2025 to 2034. Key factors driving this growth include the increasing aging population, improved reimbursement frameworks, and heightened awareness about shingles prevention and … Read more